ADA Foundation accepting Harris grant applications until April 25
The ADA Foundation is accepting applications for its 2014 Samuel Harris Fund for Children’s Dental Health Grant Program until April 25. Nonprofit organizations and agencies
The ADA Foundation is accepting applications for its 2014 Samuel Harris Fund for Children’s Dental Health Grant Program until April 25. Nonprofit organizations and agencies
The authors of new review published in the Journal of Dental Research (April 3, 2014) hope to increase the understanding of dental, oral, and craniofacial
As dental professionals, we recognize stress and try to alleviate it. That’s why we paint our dental office in soothing colors, display photos of relaxing
There are those days in dentistry when a clinician must undo what’s been done because it simply did not work. The situation is common in
Immunovaccine, a clinical-stage vaccine company, announced that its DepoVax adjuvanting technology will underlie the design of a new cancer vaccine trial for the treatment of
A quartet of proteins that play critical roles in cell replication, cell death, and DNA repair could lead to better targets for therapy against head
Health insurance marketplaces offer a variety of dental benefits, but figuring out which ones are best for pediatric coverage is complicated, according to a new
The National Council for Prescription Drug Programs (NCPDP), a not-for-profit pharmacy standards development organization, has issued a patient safety white paper on oral liquid medications
The proposed 2015 budget for the Indian Health Service (IHS) won’t address increasing oral disease, according to the ADA. The $175 million fiscal 2015 budget
Patients with throat cancer who are positive for the human papillomavirus (HPV) have a good prognosis, but until now the effect of being HPV-positive on
The new health insurance marketplaces offer a variety of dental benefits, but figuring out which ones are best for consumers and pediatric coverage is complicated,
Gene alterations may be responsible for recurrent head and neck cancer (HNC) in some patients, and an existing cancer drug may be an effective treatment,